Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet's Uveitis: Customizing Therapy according to the Clinical Features.
Luca De SimoneAlessandro InvernizziRaffaella AldigeriValentina MastrofilippoChiara MarvisiFabrizio GozziElena BollettaChantal AdaniNicolò PipitoneFrancesco MuratoreLuigi FontanaCarlo SalvaraniLuca CiminoPublished in: Ocular immunology and inflammation (2020)
Both IFX and IFN Alpha-2a were effective and well tolerated in the treatment of refractory BU using a customized approach based on the uveitis features.